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because of inaffordability, or to become self-sufficient through 
local manufacture. The expertise undoubtedly exists locally 
and it merely needs to be harnessed to produce products of 
international standard. 
In a developing country with strained financial resources the 
obvious non-medical economic benefit of such an implant 
system is local manufacture which provides employment for 
South Africans, the potential for export and savings on foreign 
exchange. It allows local surgeons an opportunity to provide 
input into the design and development of this and similar 
products and even customisation of products in selective 
cases. 
The authors wish in particular to thank Sister Juleen du Toit and 
Dr Keith Schlagbauer for arranging the follow-up radiographs and 
collating the information for review. 
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SHORT REPORT 
AN INVESTIGATION OF THE 
OCCURRENCE OF SV40 
ANTIBODIES IN SOUTH AFRICA 
H R Basetse, G Lecatsas, L J Gerber 
We developed an enzyme-linked immunosorbent assay 
(ELISA) for the detection of antibodies to simian virus 40 
(SV40) in human serum. We then used the ELISA to test for 
anti-SV40 antibodies in healthy inviduals and patients 
suffering from cancer and renal diseases. The aim of the study 
was to determine the presence of antibodies against SV40 in 
sera of individuals who received the South African poliovirus 
vaccines from 1958 to the present. Detecting such antibodies 
could give an indication of whether any of the poliovirus 
vaccines used in South Africa were ever contaminated with 
the SV40 or not. A total of 5/164 samples were repeatedly 
positive for SV40 antibodies by the ELISA. Four of the 
samples were from the healthy population group and the 
remaining 1 (1/64) was from the patient group. An SV40 
antibody-blocking assay and a Western blot were used as 
additional confirmation for the SV40 antibodies, whereas the 
Western blot assay developed a single common band on ailS 
samples. 
S Afr Med I 2002; 92: 825-828. 
Sweet and Hilleman1 first described simian virus 40 (SV40) in 
1960 as a latent infection of cell cultures derived from the 
kidneys of rhesus and cynomolgus monkeys. It belongs to the 
Papovaviridae family which includes the subfamilies 
Papillomavirinae and Polyomavirinae, with SV40 belonging to the 
Polyomavirinae subfamily.' At the time of discovery, Sweet and 
Hilleman were involved in the isolation and elimination of 
endogenous viruses from cell cultures of rhesus monkey 
kidneys.' These cell cultures were being widely used at that 
time, for the production of poliovirus and other human viral 
vaccines. Several human virus vaccines had already been 
prepared from these cell cultures by that time, the majority of 
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